NDC 64942-1929 Re-fresh Scalp Care

Rose Water And Nourish Anti-dandruff Conditioner

NDC Product Code 64942-1929

NDC 64942-1929-1

Package Description: 400 mL in 1 BOTTLE

NDC Product Information

Re-fresh Scalp Care with NDC 64942-1929 is a a human over the counter drug product labeled by Conopco, Inc. D/b/a/ Unilever. The generic name of Re-fresh Scalp Care is rose water and nourish anti-dandruff conditioner. The product's dosage form is liquid and is administered via topical form.

Dosage Form: Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.

Product Type: Human Otc Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

Re-fresh Scalp Care Active Ingredient(s)

What is the Active Ingredient(s) List?
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.


Inactive Ingredient(s)

About the Inactive Ingredient(s)
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

  • ROSEMARY (UNII: IJ67X351P9)
  • SAGE (UNII: 065C5D077J)
  • ROSA X DAMASCENA FLOWER (UNII: JWB78P295A)
  • HIPPOPHAE RHAMNOIDES FRUIT (UNII: AVL0R9111T)
  • SALIX ALBA BARK (UNII: 205MXS71H7)
  • GERANIOL (UNII: L837108USY)
  • WATER (UNII: 059QF0KO0R)
  • CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)
  • STEARAMIDOPROPYL DIMETHYLAMINE (UNII: K7VEI00UFR)
  • BEHENTRIMONIUM CHLORIDE (UNII: X7GNG3S47T)
  • COCONUT OIL (UNII: Q9L0O73W7L)
  • ARCTIUM LAPPA ROOT (UNII: 597E9BI3Z3)
  • GINKGO (UNII: 19FUJ2C58T)
  • PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
  • SODIUM BENZOATE (UNII: OJ245FE5EU)
  • DIPROPYLENE GLYCOL (UNII: E107L85C40)
  • EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)
  • .BETA.-CITRONELLOL, (R)- (UNII: P01OUT964K)
  • .ALPHA.-HEXYLCINNAMALDEHYDE (UNII: 7X6O37OK2I)
  • LINALOOL, (+/-)- (UNII: D81QY6I88E)

Administration Route(s)

What are the Administration Route(s)?
The translation of the route code submitted by the firm, indicating route of administration.

  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.

Product Labeler Information

What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.

Labeler Name: Conopco, Inc. D/b/a/ Unilever
Labeler Code: 64942
FDA Application Number: part358H What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

Marketing Category: OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph. What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Start Marketing Date: 11-01-2021 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.

Listing Expiration Date: 12-31-2022 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.

Exclude Flag: N - NO What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".

* Please review the disclaimer below.

Re-fresh Scalp Care Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Product Labeling Index

Drug Facts

Active ingredientSalicylic Acid (2.0%)

Purpose

Anti-dandruff

Use

Helps prevent and control recurrence of itching, flaking and irritation associated with dandruff.

Warnings

For external use only
When using this product Avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.
Stop use and ask a doctor if: Condition worsens or does not improve after regular use of this product as directed.

Otc - Keep Out Of Reach Of Children

Keep this and all drugs out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

For best results use at least twice per week or as directed by a doctor. Massage into scalp and hair. Rinse.

Inactive Ingredients

Water (Aqua), Cetearyl Alcohol, Stearamidopropyl Dimethylamine, Behentrimonium Chloride, Cocos Nucifera (Coconut) Oil, Propylene Glycol, Sodium Benzoate, Fragrance (Parfum), Dipropylene Glycol, Disodium EDTA, Rosa Damascena Flower Extract, Salix Alba (Willow) Bark Extract, Rosmarinus Officinalis (Rosemary) Leaf Extract, Arctium Lappa Root Extract, Ginkgo Biloba Leaf Extract, Salvia Officinalis (Sage) Leaf Extract, Hippophae Rhamnoides Fruit Extract, Citronellol, Geraniol, Hexyl Cinnamal, Linalool.

* Please review the disclaimer below.